At a glance
- Originator Takeda
- Class Antihypertensives; Vasodilators
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension; Ischaemic heart disorders
Most Recent Events
- 13 Oct 2000 Discontinued-Preclinical for Hypertension in Japan (IV)
- 13 Oct 2000 Discontinued-Preclinical for Ischaemic heart disorders in Japan (Unknown route)
- 12 Jun 2000 Profile reviewed but no significant modifications made